학술논문

Association of MMP9 with adverse features of plaque progression and residual inflammatory risk in patients with chronic coronary syndrome (CCS)
Document Type
Article
Source
In: Vascular Pharmacology. (Vascular Pharmacology, October 2022, 146)
Subject
Language
English
ISSN
18793649
15371891